Anthera Pharmaceuticals Inc 4/A
4/A · Anthera Pharmaceuticals Inc · Filed Mar 3, 2017
Insider Transaction Report
Form 4/AAmended
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2016-12-06+200,000→ 200,000 totalExercise: $1.47Exp: 2026-12-06→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This is an amendment to correct an error in the original form 4 filed on December 6, 2016. The Option vests four years as follows: 25% of the stock options shall vest one year following the vesting commencement date, with the remaining 75% of the stock options vesting in 36 equal monthly installments thereafter. The vesting commencement date is December 6, 2016. The option will expire on December 6, 2026.